A Spotlight on Our Collaborations in North America

In Search of the Next Potential Breakthroughs:

A Spotlight on Our Collaborations in North America

Welcome to our North America Spotlight report, where we share the inside track on how our Johnson & Johnson Innovation North America team collaborates to unlock the most promising science for everyone, everywhere. Explore our latest collaborations, hear from some of our partners and learn more about the different capabilities and expertise we can offer to help bring your ideas to life.

Stacy Feld
Regional Head, Johnson & Johnson Innovation,
West North America, Australia and New Zealand

Michal Preminger
Regional Head, Johnson & Johnson Innovation,
East North America

Some Examples of What We Can Achieve Together

Throughout North America, our collaborations focus on highly differentiated early-stage innovations that aim to extend and improve the lives of patients and consumers, not only in this region but around the world. Hear directly from our partners and explore our latest collaborations across the health landscape − from advancing innovations in response to the COVID-19 pandemic and potential future health security threats − to enabling patient access to specialist-level care with telemedicine and treatment delivery. We hope you enjoy this glimpse into how, together with our partners, we are working to advance the next wave of innovators.

A great idea can come from anywhere. Let`s connect!

Consumer and Public Health


Enabling Potential Earlier Detection of Respiratory Infections via Home-Use Diagnostics


Preparing for and Responding to Potential Health Security Threats

"Our partnership with JLABS is bringing forward early innovative ideas…"


Enabling Patient Access to Specialist-Level Care with Telemedicine and Treatment Delivery

"Our collaboration with Johnson & Johnson Innovation has accelerated both the delivery of our care model and our ability to reach more patients."


Advancing Digital Biomarkers to Address Mood Disorders

Digital Health


Accelerating the Transformation of Digital Pathology



Treating Long Bone Defects with 3D-Printing



Exploring a potential first-in-class solution for autosomal dominant polycystic kidney disease


Accelerating Development of the COVID-19 Vaccine


Developing New Generation of Integrin Therapies for Treating Chronic Diseases


Developing and Commercializing Drug-Fc Conjugates for the Prevention and Treatment of Influenza

"Our collaboration with Janssen … aims to provide truly universal protection against all strains of the flu, for all people in need."


Developing Engineered HSC Transplants Combined with Bi-Specific Antibody Therapies for AML


Advancing Novel Approaches to Therapeutic Protein Delivery

"The collaboration has allowed us to branch our platform out into new therapeutic approaches and indications."

Trex Bio

Discovering Novel Tissue-Targeted Therapeutics for Immunology and Inflammation

Behind all great science is a scientist seeking to make a difference. Hear from members of our Johnson & Johnson Innovation North America partner network on what inspires them to work in healthcare.

Interested in Collaborating?

We engage and collaborate with entrepreneurs, academia, investors, accelerators, incubators and universities, at various stages of development, with the aim to enable and accelerate transformational innovation and bring it to patients.

Our ‘co-creation model’ is designed to give you access to a full range of incubation and acceleration ‘ingredients’, as well as Johnson & Johnson’s network of scientific and commercial experts.


We always felt we could help patients in a unique way. Johnson & Johnson brought tremendous resources and expertise to the table. Their collaborative mindset and real belief in our technology helped to circumvent a variety of challenges, and truly enabled these innovative technologies to reach societal impact.

Dr. William L. Murphy
Scientific Co-Founder, Tissue Regeneration Systems
Harvey D. Spangler Professor of Biomedical Engineering and Orthopedics and Rehabilitation, University of Wisconsin

Curious About What We Offer?

Depending on where your idea is in its lifecycle, you can easily tap into our range of customizable collaboration models and capabilities, including:


Early Innovation Partnering & Deal-Making


Incubation and Acceleration with JLABS


Venture Investment with JJDC


NewCo Creation Opportunities


Late-Stage Partnering

Our Strategic Therapeutic Areas of Focus

Making an Impact Together
Across North America Since 2013

By connecting the best science, technology and entrepreneurs to our resources, tools and expertise, our goal is to expand and accelerate solutions that aim to address the toughest healthcare challenges and improve the lives of patients and consumers around the world. Highlights of our reach and our impact in driving innovation across North America include:

Johnson & Johnson Innovation – JJDC, Inc. (JJDC) provided essential capital with the aim to help accelerate Paige’s growth and impact on the clinic. Now, at the scientific level, the winning combination of therapeutics married with Paige’s evolving digital diagnostics and biomarkers has the potential to improve outcomes of patients with cancer.

Thomas Fuchs, Dr.Sc.
Founder and Chief Scientist, Paige.AI



Supporting 16 companies in North America through BLUE KNIGHT™, a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA). These companies are working to develop potential solutions to prepare for and respond to known and unknown public health threats.

Connect with Us

If you’re working on an early-stage innovation that has the potential to transform into the next breakthrough idea or solution, we want to hear from you.

Visit our website for more information
Follow us on Twitter
Subscribe to our e-newsletters